{"id":"NCT02684357","sponsor":"AbbVie","briefTitle":"BI 655066 Versus Placebo & Active Comparator (Ustekinumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis","officialTitle":"BI 655066 Versus Ustekinumab and Placebo Comparators in a Randomized Double Blind trIal for Maintenance Use in Moderate to Severe Plaque Type Psoriasis-2 (UltIMMa-2)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-03","primaryCompletion":"2016-12","completion":"2017-09","firstPosted":"2016-02-18","resultsPosted":"2019-07-15","lastUpdate":"2021-08-23"},"enrollment":577,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Psoriasis"],"interventions":[{"type":"DRUG","name":"risankizumab","otherNames":["BI 655066","ABBV-066","SKYRIZI"]},{"type":"DRUG","name":"ustekinumab","otherNames":[]},{"type":"DRUG","name":"placebo for risankizumab","otherNames":[]},{"type":"DRUG","name":"placebo for ustekinumab","otherNames":[]}],"arms":[{"label":"Placebo (Part A)","type":"PLACEBO_COMPARATOR"},{"label":"Ustekinumab (Part A)","type":"ACTIVE_COMPARATOR"},{"label":"Risankizumab (Part A)","type":"EXPERIMENTAL"}],"summary":"This is a randomized double blind, double dummy, placebo and active comparator controlled, parallel design study that is being performed to assess the safety and efficacy of risankizumab (BI 655066) to support registration for the treatment of moderate to severe chronic plaque psoriasis in adult patients.","primaryOutcome":{"measure":"Percentage of Participants Achieving 90% Improvement in Psoriasis Area and Severity Index (PASI) Score (PASI90) at Week 16 in Participants Who Received Risankizumab Compared With Placebo (Part A)","timeFrame":"Week 16","effectByArm":[{"arm":"Placebo (Part A)","deltaMin":2,"sd":null},{"arm":"Risankizumab (Part A)","deltaMin":74.8,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"< 0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":12},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["97359","35839335","34921669","33052382","31667790","31054118","30097359"],"seeAlso":["http://rxabbvie.com"]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":98},"commonTop":["Viral upper respiratory tract infection","Upper respiratory tract infection","Diarrhoea","Influenza"]}}